Stem Cell Banking Market Growth Analysis: Opportunities & Forecasts According to a newly published market research report by 24LifeSciences, global stem cell banking market was valued at USD 1,761 Million in 2025 and is projected to grow from USD 1,896 million in 2026 to reach USD 2,943 Million by 2034, growing at a compound annual growth rate (CAGR) of 7.8% during the forecast period. Stem cell banking is the process of collecting, processing, and cryogenically preserving stem cells from sources like umbilical cord blood, cord tissue, and adult tissues for potential future therapeutic use. This service, often termed a biological insurance policy, plays an increasingly crucial role in regenerative medicine, offering potential treatments for a wide array of conditions from blood cancers like leukemia and lymphoma to genetic disorders and potential future applications in neurological and autoimmune diseases. Its importance is underscored by the growing arsenal of stem cell-based therapies entering clinical practice. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/4282/stem-cell-banking-market-market

Pre-Pregnancy Genetic Testing Market Outlook 2026: Size, Trends & Key Players According to a newly published market research report by 24LifeSciences, global pre-pregnancy genetic testing market is valued at USD 1.83 billion in 2026 and is projected to reach USD 3.87 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.5% during the forecast period. Pre-pregnancy genetic testing, clinically known as carrier screening, is a vital diagnostic tool used to identify individuals or couples who carry gene mutations that could lead to serious genetic disorders in their offspring, such as cystic fibrosis, spinal muscular atrophy (SMA), and fragile X syndrome. These tests, typically performed via blood or saliva samples, provide essential information for informed family planning and reproductive decision-making. The increasing integration of advanced genomic technologies and rising awareness about hereditary conditions are fundamentally transforming preconception care worldwide. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9121/pre-pregnancy-genetic-testing-market

Orphan Diseases Market to Reach USD 834 million by 2034 | Growth Trends & Insights According to a newly published market research report by 24LifeSciences, global orphan diseases market is valued at USD 315 million in 2026 and is projected to reach USD 834 million by 2034, growing at a compound annual growth rate (CAGR) of 15.3% during the forecast period. An orphan disease is officially defined as a condition affecting fewer than 200,000 people in the United States, encompassing a wide spectrum of disorders from more recognized conditions like cystic fibrosis and ALS (Lou Gehrig's disease) to rare genetic disorders such as Hutchinson-Gilford progeria syndrome. The vast majority of these diseases are genetic in origin, creating significant challenges and opportunities for targeted therapeutic development. These conditions represent some of the most complex medical challenges facing modern healthcare, requiring specialized approaches to both diagnosis and treatment. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9568/orphan-diseases-market